The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosisXiaowei Zhang, Yuanbo Liu|BMC Cancer|2022Cited by 33
Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphomaJing Liu, Yuanbo Liu|Oncology Reports|2016Cited by 18
The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.Yuanbo Liu|Research Square|2021Cited by 1